Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis

Adam Booth, Angus Bruno Reed, Sonia Ponzo, Arrash Yassaee, Mert Aral, David Plans, Alain Labrique, Diwakar Mohan, Adam Booth, Angus Bruno Reed, Sonia Ponzo, Arrash Yassaee, Mert Aral, David Plans, Alain Labrique, Diwakar Mohan

Abstract

Aim: COVID-19 clinical presentation is heterogeneous, ranging from asymptomatic to severe cases. While there are a number of early publications relating to risk factors for COVID-19 infection, low sample size and heterogeneity in study design impacted consolidation of early findings. There is a pressing need to identify the factors which predispose patients to severe cases of COVID-19. For rapid and widespread risk stratification, these factors should be easily obtainable, inexpensive, and avoid invasive clinical procedures. The aim of our study is to fill this knowledge gap by systematically mapping all the available evidence on the association of various clinical, demographic, and lifestyle variables with the risk of specific adverse outcomes in patients with COVID-19.

Methods: The systematic review was conducted using standardized methodology, searching two electronic databases (PubMed and SCOPUS) for relevant literature published between 1st January 2020 and 9th July 2020. Included studies reported characteristics of patients with COVID-19 while reporting outcomes relating to disease severity. In the case of sufficient comparable data, meta-analyses were conducted to estimate risk of each variable.

Results: Seventy-six studies were identified, with a total of 17,860,001 patients across 14 countries. The studies were highly heterogeneous in terms of the sample under study, outcomes, and risk measures reported. A large number of risk factors were presented for COVID-19. Commonly reported variables for adverse outcome from COVID-19 comprised patient characteristics, including age >75 (OR: 2.65, 95% CI: 1.81-3.90), male sex (OR: 2.05, 95% CI: 1.39-3.04) and severe obesity (OR: 2.57, 95% CI: 1.31-5.05). Active cancer (OR: 1.46, 95% CI: 1.04-2.04) was associated with increased risk of severe outcome. A number of common symptoms and vital measures (respiratory rate and SpO2) also suggested elevated risk profiles.

Conclusions: Based on the findings of this study, a range of easily assessed parameters are valuable to predict elevated risk of severe illness and mortality as a result of COVID-19, including patient characteristics and detailed comorbidities, alongside the novel inclusion of real-time symptoms and vital measurements.

Conflict of interest statement

A.B, A.B.R., S.P., D.P., A.Y., M.A., are employees of Huma Therapeutics Ltd. D.M & AL declare that they have no conflict of interests to report. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1. PRISMA diagram.
Fig 1. PRISMA diagram.
Fig 2. Forest plot for the association…
Fig 2. Forest plot for the association of patient characteristics (age, sex, and severe obesity) with severe outcomes from COVID-19 using a random-effects model.
Fig 3. Forest plot for the association…
Fig 3. Forest plot for the association of comorbidities (diabetes, hypertension, chronic kidney disease, and active cancer) with severe outcomes from COVID-19 using a random-effects model.
Fig 4. Funnel plot highlighting publication bias…
Fig 4. Funnel plot highlighting publication bias for male sex as risk factor for severe COVID-19 outcome.
1 = Petrilli et al., 2020; 2 = Lassale et al., 2020; 3 = Price-Haywood et al., 2020; 4 = Huang et al., 2020b; 5 = Suleyman et al., 2020; 6 = Kalligeros et al., 2020; 7 = Simonnet et al., 2020; 8 = Palaiodimos et al., 2020; 9 = Chen et al. 2020; 10 = Shi et al., 2020; 11 = Zhang et al, 2020.

References

    1. WHO. Weekly epidemiological update—17 November 2020. World Health Organization; 2020. Nov. Available:
    1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet Lond Engl. 2020;395: 497–506. 10.1016/S0140-6736(20)30183-5
    1. Vaira LA, Hopkins C, Salzano G, Petrocelli M, Melis A, Cucurullo M, et al.. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study. Head Neck. 2020;42: 1560–1569. 10.1002/hed.26269
    1. Vaira LA, Deiana G, Fois AG, Pirina P, Madeddu G, Vito AD, et al.. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head Neck. 2020;42: 1252–1258. 10.1002/hed.26204
    1. Chen R, Yu Y, Li W, Liu Y, Lu J, Chen F, et al.. Gastrointestinal Symptoms Associated With Unfavorable Prognosis of COVID-19 Patients: A Retrospective Study. Front Med. 2020;7. 10.3389/fmed.2020.608259
    1. Guarneri C, Rullo EV, Gallizzi R, Ceccarelli M, Cannavò SP, Nunnari G. Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19. J Eur Acad Dermatol Venereol. 2020;34: e449–e450. 10.1111/jdv.16669
    1. Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, Loh J, et al.. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. JAMA. 2020;323: 1488–1494. 10.1001/jama.2020.3204
    1. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al.. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8: 420–422. 10.1016/S2213-2600(20)30076-X
    1. Lu X, Wang Y, Chen T, Wang J, Yan F. Classification of COVID-19 in intensive care patients. Crit Care. 2020;24: 399. 10.1186/s13054-020-03127-7
    1. Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al.. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20: 669–677. 10.1016/S1473-3099(20)30243-7
    1. Lopez M, Bell K, Annaswamy T, Juengst S, Ifejika N. COVID-19 Guide for the Rehabilitation Clinician: A Review of Nonpulmonary Manifestations and Complications. Am J Phys Med Rehabil. 2020;99: 669–673. 10.1097/PHM.0000000000001479
    1. Maxwell E. Living with Covid19. National Institute for Health Research; 2020. October. 10.3310/themedreview_41169
    1. Sheehy LM. Considerations for Postacute Rehabilitation for Survivors of COVID-19. JMIR Public Health Surveill. 2020;6: e19462. 10.2196/19462
    1. Ferrer R. COVID-19 Pandemic: the greatest challenge in the history of critical care. Med Intensiva Engl Ed. 2020;44: 323–324. 10.1016/j.medin.2020.04.002
    1. Iacobucci G. Covid-19: all non-urgent elective surgery is suspended for at least three months in England. BMJ. 2020; m1106. 10.1136/bmj.m1106
    1. Lai AG, Pasea L, Banerjee A, Hall G, Denaxas S, Chang WH, et al.. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study. BMJ Open. 2020;10: e043828. 10.1136/bmjopen-2020-043828
    1. Ferguson N, Laydon D, Nedjati Gilani G, Imai N, Ainslie K, Baguelin M, et al.. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. Imperial College London; 2020. March. 10.25561/77482
    1. UK GOV. Government secures 5 million doses of Moderna vaccine. In: [Internet]. 16 Nov 2020 [cited 18 Nov 2020]. Available:
    1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395: 1054–1062. 10.1016/S0140-6736(20)30566-3
    1. Xu X-W, Wu X-X, Jiang X-G, Xu K-J, Ying L-J, Ma C-L, et al.. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; m606. 10.1136/bmj.m606
    1. Modesti PA, Reboldi G, Cappuccio FP, Agyemang C, Remuzzi G, Rapi S, et al.. Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-Analysis. PLOS ONE. 2016;11: e0147601. 10.1371/journal.pone.0147601
    1. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al.. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200: e45–e67. 10.1164/rccm.201908-1581ST
    1. National Health Commission of the People’s Republic of China. Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment (7th edition). [cited 13 Dec 2020]. Available:
    1. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2019. Available:
    1. Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22: 153–160. 10.1136/ebmental-2019-300117
    1. Cao J, Tu W-J, Cheng W, Yu L, Liu Y-K, Hu X, et al.. Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, China. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020. 10.1093/cid/ciaa243
    1. Chen L, Yu J, He W, Chen L, Yuan G, Dong F, et al.. Risk factors for death in 1859 subjects with COVID-19. Leukemia. 2020;34: 2173–2183. 10.1038/s41375-020-0911-0
    1. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al.. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368: m1091. 10.1136/bmj.m1091
    1. Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T, et al.. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020;80: e1–e6. 10.1016/j.jinf.2020.03.004
    1. Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al.. Patients with cancer appear more vulnerable to SARS-CoV-2: A multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10: 783. 10.1158/-20-0422
    1. Deng Y, Liu W, Liu K, Fang Y-Y, Shang J, Zhou L, et al.. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020;133: 1261–1267. 10.1097/CM9.0000000000000824
    1. Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M, et al.. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020;55. 10.1183/13993003.00524–2020
    1. Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, et al.. COVID-19 with Different Severities: A Multicenter Study of Clinical Features. Am J Respir Crit Care Med. 2020;201: 1380–1388. 10.1164/rccm.202002-0445OC
    1. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al.. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55. 10.1183/13993003.00547-2020
    1. Huang S, Wang J, Liu F, Liu J, Cao G, Yang C, et al.. COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study. Hypertens Res. 2020. 10.1038/s41440-020-0485-2
    1. Huang R, Zhu L, Xue L, Liu L, Yan X, Wang J, et al.. Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study. PLoS Negl Trop Dis. 2020;14: e0008280. 10.1371/journal.pntd.0008280
    1. Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, et al.. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69: 1002–1009. 10.1136/gutjnl-2020-320926
    1. Li J, Huang DQ, Zou B, Yang H, Hui WZ, Rui F, et al.. Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2020;n/a. 10.1002/jmv.26424
    1. Li H, Tian S, Chen T, Cui Z, Shi N, Zhong X, et al.. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19. Diabetes Obes Metab. 2020. 10.1111/dom.14099
    1. Li H, Xiang X, Ren H, Xu L, Zhao L, Chen X, et al.. Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis. J Infect. 2020;80: 646–655. 10.1016/j.jinf.2020.03.035
    1. Liang W, Liang H, Ou L, Chen B, Chen A, Li C, et al.. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients with COVID-19. JAMA Intern Med. 2020. 10.1001/jamainternmed.2020.2033
    1. Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, et al.. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020;127: 104370. 10.1016/j.jcv.2020.104370
    1. Liu F, Zhang Q, Huang C, Shi C, Wang L, Shi N, et al.. CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients. Theranostics. 2020;10: 5613–5622. 10.7150/thno.45985
    1. Pei G, Zhang Z, Peng J, Liu L, Zhang C, Yu C, et al.. Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia. J Am Soc Nephrol. 2020;31: 1157–1165. 10.1681/ASN.2020030276
    1. Qin C, Zhou L, Hu Z, Yang S, Zhang S, Chen M, et al.. Clinical Characteristics and Outcomes of COVID-19 Patients with a History of Stroke in Wuhan, China. Stroke. 2020; 2219–2223. 10.1161/STROKEAHA.120.030365
    1. Ren H, Yang Y, Wang F, Yan Y, Shi X, Dong K, et al.. Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19. Cardiovasc Diabetol. 2020;19: 58. 10.1186/s12933-020-01035-2
    1. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46: 846–848. 10.1007/s00134-020-05991-x
    1. Shi Q, Zhang X, Jiang F, Hu N, Bimu C, Feng J, et al.. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study. Diabetes Care. 2020;43: 1382–1391. 10.2337/dc20-0598
    1. Shi Y, Yu X, Zhao H, Wang H, Zhao R, Sheng J. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan. Crit Care. 2020;24: 108. 10.1186/s13054-020-2833-7
    1. Wang D, Yin Y, Hu C, Liu X, Zhang X, Zhou S, et al.. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Crit Care. 2020;24: 188. 10.1186/s13054-020-02895-6
    1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al.. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA—J Am Med Assoc. 2020;323: 1061–1069. 10.1001/jama.2020.1585
    1. Wang R, Pan M, Zhang X, Han M, Fan X, Zhao F, et al.. Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China. Int J Infect Dis. 2020;95: 421–428. 10.1016/j.ijid.2020.03.070
    1. Wang L, He W, Yu X, Hu D, Bao M, Liu H, et al.. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020;80: 639–645. 10.1016/j.jinf.2020.03.019
    1. Wang Y, Lu X, Li Y, Chen H, Chen T, Su N, et al.. Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19. Am J Respir Crit Care Med. 2020;201: 1430–1434. 10.1164/rccm.202003-0736LE
    1. Wu F, Zhou Y, Wang Z, Xie M, Shi Z, Tang Z, et al.. Clinical characteristics of COVID-19 infection in chronic obstructive pulmonary disease: A multicenter, retrospective, observational study. J Thorac Dis. 2020;12: 1811–1823. 10.21037/jtd-20-1914
    1. Xie J, Covassin N, Fan Z, Singh P, Gao W, Li G, et al.. Association Between Hypoxemia and Mortality in Patients With COVID-19. Mayo Clin Proc. 2020;95: 1138–1147. 10.1016/j.mayocp.2020.04.006
    1. Yan Y, Yang Y, Wang F, Ren H, Zhang S, Shi X, et al.. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ Open Diabetes Res Care. 2020;8. 10.1136/bmjdrc-2020-001343
    1. Yang L, Liu J, Zhang R, Li M, Li Z, Zhou X, et al.. Epidemiological and clinical features of 200 hospitalized patients with corona virus disease 2019 outside Wuhan, China: A descriptive study. J Clin Virol. 2020;129. 10.1016/j.jcv.2020.104475
    1. Yao Q, Wang P, Wang X, Qie G, Meng M, Tong X, et al.. A retrospective study of risk factors for severe acute respiratory syndrome coronavirus 2 infections in hospitalized adult patients. Pol Arch Intern Med. 2020;130: 390–399. 10.20452/pamw.15312
    1. Ye C, Zhang S, Zhang X, Cai H, Gu J, Lian J, et al.. Impact of comorbidities on patients with COVID-19: A large retrospective study in Zhejiang, China. J Med Virol. 2020. 10.1002/jmv.26183
    1. Yu Q, Wang Y, Huang S, Liu S, Zhou Z, Zhang S, et al.. Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients. Theranostics. 2020;10: 5641–5648. 10.7150/thno.46465
    1. Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, et al.. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol. 2020;127: 104364. 10.1016/j.jcv.2020.104364
    1. Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, et al.. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020;26: 767–772. 10.1016/j.cmi.2020.04.012
    1. Zhang J, Yu M, Tong S, Liu LY, Tang LV. Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China. J Clin Virol. 2020;127: 104392. 10.1016/j.jcv.2020.104392
    1. Zhang X, Cai H, Hu J, Lian J, Gu J, Zhang S, et al.. Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings. Int J Infect Dis. 2020;94: 81–87. 10.1016/j.ijid.2020.03.040
    1. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al.. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81: e16–e25. 10.1016/j.jinf.2020.04.021
    1. Zhou Y, He Y, Yang H, Yu H, Wang T, Chen Z, et al.. Development and validation a nomogram for predicting the risk of severe COVID-19: A multi-center study in Sichuan, China. PLoS One. 2020;15: e0233328. 10.1371/journal.pone.0233328
    1. Argenziano MG, Bruce SL, Slater CL, Tiao JR, Baldwin MR, Barr RG, et al.. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ. 2020;369: m1996. 10.1136/bmj.m1996
    1. Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al.. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395: 1763–1770. 10.1016/S0140-6736(20)31189-2
    1. D’Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Fu X, Gravallese EM, et al.. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: A comparative cohort study from a US “hot spot.” Ann Rheum Dis. 2020. 10.1136/annrheumdis-2020-217888
    1. Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, et al.. Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US. JAMA Intern Med. 2020. 10.1001/jamainternmed.2020.3596
    1. Hajifathalian K, Kumar S, Newberry C, Shah S, Fortune B, Krisko T, et al.. Obesity is associated with worse outcomes in COVID-19: Analysis of Early Data From New York City. Obesity. 2020;n/a. 10.1002/oby.22923
    1. Imam Z, Odish F, Gill I, O’Connor D, Armstrong J, Vanood A, et al.. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. J Intern Med. 2020;n/a. 10.1111/joim.13119
    1. Kalligeros M, Shehadeh F, Mylona EK, Benitez G, Beckwith CG, Chan PA, et al.. Association of Obesity with Disease Severity Among Patients with Coronavirus Disease 2019. Obesity. 2020;28: 1200–1204. 10.1002/oby.22859
    1. Kim L, Garg S, O’Halloran A, Whitaker M, Pham H, Anderson EJ, et al.. Risk Factors for Intensive Care Unit Admission and In-hospital Mortality among Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET). Clin Infect Dis. 2020. 10.1093/cid/ciaa1012
    1. Latz CA, DeCarlo C, Boitano L, Png CYM, Patell R, Conrad MF, et al.. Blood type and outcomes in patients with COVID-19. Ann Hematol. 2020. 10.1007/s00277-020-04169-1
    1. Okoh AK, Sossou C, Dangayach NS, Meledathu S, Phillips O, Raczek C, et al.. Coronavirus disease 19 in minority populations of Newark, New Jersey. Int J Equity Health. 2020;19: 93. 10.1186/s12939-020-01208-1
    1. Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, et al.. Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108. 10.1016/j.metabol.2020.154262
    1. Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, et al.. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369: m1966. 10.1136/bmj.m1966
    1. Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and Mortality among Black Patients and White Patients with Covid-19. N Engl J Med. 2020;382: 2534–2543. 10.1056/NEJMsa2011686
    1. Ramlall V, Thangaraj PM, Meydan C, Foox J, Butler D, Kim J, et al.. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection. Nat Med. 2020. 10.1038/s41591-020-1021-2
    1. Suleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A, et al.. Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. JAMA Netw Open. 2020;3: e2012270. 10.1001/jamanetworkopen.2020.12270
    1. Giacomelli A, Ridolfo AL, Milazzo L, Oreni L, Bernacchia D, Siano M, et al.. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study. Pharmacol Res. 2020;158. 10.1016/j.phrs.2020.104931
    1. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al.. Baseline Characteristics and Outcomes of 1591 Patients Infected with SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA—J Am Med Assoc. 2020;323: 1574–1581. 10.1001/jama.2020.5394
    1. Masetti C, Generali E, Colapietro F, Voza A, Cecconi M, Messina A, et al.. High mortality in COVID-19 patients with mild respiratory disease. Eur J Clin Invest. 2020. 10.1111/eci.13314
    1. Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, et al.. Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020. 10.1056/NEJMoa2020283
    1. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al.. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369: m1985. 10.1136/bmj.m1985
    1. Lassale C, Gaye B, Hamer M, Gale CR, Batty GD. Ethnic disparities in hospitalisation for COVID-19 in England: The role of socioeconomic factors, mental health, and inflammatory and pro-inflammatory factors in a community-based cohort study. Brain Behav Immun. 2020;88: 44–49. 10.1016/j.bbi.2020.05.074
    1. Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al.. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020. 10.1038/s41586-020-2521-4
    1. Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A, et al.. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. J Clin Endocrinol Metab. 2020;105. 10.1210/clinem/dgaa346
    1. Kammar-García A, Vidal-Mayo JJ, Vera-Zertuche JM, Lazcano-Hernández M, Vera-López O, Segura-Badilla O, et al.. IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT. Rev Investig Clin Organo Hosp Enfermedades Nutr. 2020;72: 151–158. 10.24875/RIC.20000207
    1. Hou W, Zhang W, Jin R, Liang L, Xu B, Hu Z. Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study. Infect Lond. 2020;52: 498–505. 10.1080/23744235.2020.1759817
    1. Lee Y, Min P, Lee S, Kim SW. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients. J Korean Med Sci. 2020;35: e174. 10.3346/jkms.2020.35.e174
    1. Göker H, Aladağ-Karakulak E, Demiroğlu H, Ayaz CM, Büyükaşik Y, İnkaya AC, et al.. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome. Turk J Med Sci. 2020;50: 679–683. 10.3906/sag-2005-395
    1. Baqui P, Bica I, Marra V, Ercole A, van der Schaar M. Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study. Lancet Glob Health. 2020;8: e1018–e1026. 10.1016/S2214-109X(20)30285-0
    1. Israelsen SB, Kristiansen KT, Hindsberger B, Ulrik CS, Andersen O, Jensen M, et al.. Characteristics of patients with COVID-19 pneumonia at Hvidovre Hospital, March-April 2020. Dan Med J. 2020;67.
    1. Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al.. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity. 2020;28: 1195–1199. 10.1002/oby.22831
    1. Itelman E, Wasserstrum Y, Segev A, Avaky C, Negru L, Cohen D, et al.. Clinical Characterization of 162 COVID-19 patients in Israel: Preliminary Report from a Large Tertiary Center. Isr Med Assoc J. 2020;22: 271–274.
    1. Shahriarirad R, Khodamoradi Z, Erfani A, Hosseinpour H, Ranjbar K, Emami Y, et al.. Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran. BMC Infect Dis. 2020;20. 10.1186/s12879-020-05128-x
    1. Nowak B, Szymański P, Pańkowski I, Szarowska A, Życińska K, Rogowski W, et al.. Clinical characteristics and short-term outcomes of patients with coronavirus disease 2019: a retrospective single-center experience of a designated hospital in Poland. Pol Arch Intern Med. 2020;130: 407–411. 10.20452/pamw.15361
    1. Li Q, Cao Y, Chen L, Wu D, Yu J, Wang H, et al.. Hematological features of persons with COVID-19. Leukemia. 2020;34: 2163–2172. 10.1038/s41375-020-0910-1
    1. Zheng F, Tang W, Li H, Huang YX, Xie YL, Zhou ZG. Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha. Eur Rev Med Pharmacol Sci. 2020;24: 3404–3410. 10.26355/eurrev_202003_20711
    1. Gold MS, Sehayek D, Gabrielli S, Zhang X, McCusker C, Ben-Shoshan M. COVID-19 and comorbidities: a systematic review and meta-analysis. Postgrad Med. 2020;0: 1–7. 10.1080/00325481.2020.1786964
    1. Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. Infection. 2020; 1–14. 10.1007/s15010-020-01509-1
    1. Wynants L, Calster BV, Collins GS, Riley RD, Heinze G, Schuit E, et al.. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ. 2020;369. 10.1136/bmj.m1328
    1. Al Hassan H, Cocks E, Jesani L, Lewis S, Szakmany T. Clinical Risk Prediction Scores in Coronavirus Disease 2019: Beware of Low Validity and Clinical Utility. Crit Care Explor. 2020;2. 10.1097/CCE.0000000000000253
    1. Moons KGM, Altman DG, Reitsma JB, Ioannidis JPA, Macaskill P, Steyerberg EW, et al.. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162: W1–73. 10.7326/M14-0698
    1. Mahase E. Covid-19: What do we know about “long covid”? BMJ. 2020;370. 10.1136/bmj.m2815
    1. Kelada M, Anto A, Dave K, Saleh SN. The Role of Sex in the Risk of Mortality From COVID-19 Amongst Adult Patients: A Systematic Review. Cureus. 2020;12. 10.7759/cureus.10114
    1. Mahase E. Covid-19: Why are age and obesity risk factors for serious disease? BMJ. 2020;371. 10.1136/bmj.m4130
    1. Farsalinos K, Barbouni A, Niaura R. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Intern Emerg Med. 2020; 1–8. 10.1007/s11739-020-02355-7
    1. Petersen I, Phillips A. Three Quarters of People with SARS-CoV-2 Infection are Asymptomatic: Analysis of English Household Survey Data. Clin Epidemiol. 2020;Volume 12: 1039–1043. 10.2147/CLEP.S276825
    1. Liao D, Zhou F, Luo L, Xu M, Wang H, Xia J, et al.. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol. 2020;7: e671–e678. 10.1016/S2352-3026(20)30217-9
    1. Public Health England. Beyond the Data: Understanding the Impact of COVID-19 on BAME Communities. 2020 Jun.
    1. UK GOV. Quarterly report on progress to address COVID-19 health inequalities. Race Disparity Unit, Cabinet Office; 2020. October. Available:
    1. WHO. Global COVID-19 Clinical Platform: Rapid core case report form (CRF). World Health Organization; 2020. August. Report No.: WHO/2019-nCoV/Clinical_CRF/2020.4. Available:
    1. Clift AK, Coupland CAC, Keogh RH, Diaz-Ordaz K, Williamson E, Harrison EM, et al.. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ. 2020;371. 10.1136/bmj.m3731
    1. Knight SR, Ho A, Pius R, Buchan I, Carson G, Drake TM, et al.. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370. 10.1136/bmj.m3339
    1. CO-CIN. COVID-19—Time from symptom onset until death in UK hospitalised patients, 7 October 2020. Scientific Advisory Group for Emergencies; 2020. October. Available:
    1. Thornton J. The “virtual wards” supporting patients with covid-19 in the community. BMJ. 2020;369. 10.1136/bmj.m2119

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する